BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 37776473)

  • 1. Promethazine inhibits proliferation and promotes apoptosis in colorectal cancer cells by suppressing the PI3K/AKT pathway.
    Tan X; Gong L; Li X; Zhang X; Sun J; Luo X; Wang Q; Chen J; Xie L; Han S
    Biomed Pharmacother; 2021 Nov; 143():112174. PubMed ID: 34560542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. eIf3a mediates malignant biological behaviors in colorectal cancer through the PI3K/AKT signaling pathway.
    Huo C; Wu D; Li X; Zhang Y; Hu B; Zhang T; Ren J; Wang T; Liu Y
    Cancer Biol Ther; 2024 Dec; 25(1):2355703. PubMed ID: 38782896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of coptisine derivative EHLJ7 on colorectal cancer by inhibiting PI3K/AKT pathway.
    Chai C; Tang X; Chi X; Li X; Zhang H; Wu L
    Cell Signal; 2024 Apr; 116():111053. PubMed ID: 38224723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of ANP32E inhibits colorectal cancer cell growth and glycolysis by regulating the AKT/mTOR pathway.
    Liu J; Liu Y; Zhao Q
    Open Life Sci; 2024; 19(1):20220817. PubMed ID: 38585643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CORO1C is Associated With Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer.
    Wang Z; Jia L; Sun Y; Li C; Zhang L; Wang X; Chen H
    Front Mol Biosci; 2021; 8():682594. PubMed ID: 34179087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis significance and potential association between ALDOA and AKT expression in colorectal cancer.
    Xu M; Xi S; Li H; Xia Y; Mei G; Cheng Z
    Sci Rep; 2024 Mar; 14(1):6488. PubMed ID: 38499636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-Specificity Phosphatase 4 Promotes Malignant Features in Colorectal Cancer Through Cyclic-AMP Response Element Binding Protein/Protein Kinase CAMP-Activated Catalytic Subunit Beta Activation.
    Pei W; Yin W; Yu T; Zhang X; Zhang Q; Yang X; Shi C; Shen W; Liu G
    Dig Dis Sci; 2024 Jun; ():. PubMed ID: 38824257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rupatadine inhibits colorectal cancer cell proliferation through the PIP5K1A/Akt/CDK2 pathway.
    Jiang L; Zhang Z; Luo Z; Li L; Yuan S; Cui M; He K; Xiao J
    Biomed Pharmacother; 2024 Jun; 176():116826. PubMed ID: 38838507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a novel small-molecule activator of SIRT3 that inhibits cell proliferation and migration by apoptosis and autophagy-dependent cell death pathways in colorectal cancer.
    Mou Y; Chen Y; Fan Z; Ye L; Hu B; Han B; Wang G
    Bioorg Chem; 2024 May; 146():107327. PubMed ID: 38579616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AQP8 inhibits colorectal cancer growth and metastasis by down-regulating PI3K/AKT signaling and PCDH7 expression.
    Wu Q; Yang ZF; Wang KJ; Feng XY; Lv ZJ; Li Y; Jian ZX
    Am J Cancer Res; 2018; 8(2):266-279. PubMed ID: 29511597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of ERO1α in Modulating Cancer Progression and Immune Escape.
    Johnson BD; Geldenhuys WJ; Hazlehurst LA
    J Cancer Immunol (Wilmington); 2020; 2(3):103-115. PubMed ID: 33615311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer.
    Gupta N; Park JE; Tse W; Low JK; Kon OL; McCarthy N; Sze SK
    Oncotarget; 2019 Oct; 10(57):5970-5982. PubMed ID: 31666928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNAi Screening Identifies that TEX10 Promotes the Proliferation of Colorectal Cancer Cells by Increasing NF-
    Wang Z; Sheng C; Kan G; Yao C; Geng R; Chen S
    Adv Sci (Weinh); 2020 Sep; 7(17):2000593. PubMed ID: 32995120
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Zhang S; Huang L; Zeng Y; Gao G; Wu H; Li D; Guo R
    ACS Omega; 2024 May; 9(19):21116-21126. PubMed ID: 38764627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum to "Promethazine inhibits proliferation and promotes apoptosis in colorectal cancer cells by suppressing the PI3K/AKT pathway" [Biomed. Pharmacotherapy 143(2021)112174].
    Tan X; Gong L; Li X; Zhang X; Sun J; Luo X; Wang Q; Chen J; Xie L; Han S
    Biomed Pharmacother; 2024 Jun; ():116913. PubMed ID: 38876934
    [No Abstract]   [Full Text] [Related]  

  • 16. ERO1α promotes the proliferation and inhibits apoptosis of colorectal cancer cells by regulating the PI3K/AKT pathway.
    Wu M; Li R; Qin J; Wang Z; Guo J; Lv F; Wang G; Huang Y
    J Mol Histol; 2023 Dec; 54(6):621-631. PubMed ID: 37776473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of GRHL2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the PI3K/Akt pathway.
    Hu F; He Z; Sun C; Rong D
    Gene; 2019 Jun; 700():96-104. PubMed ID: 30917932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
    Yin F; Huang X; Xuan Y
    Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Noncoding RNA PlncRNA-1 Promotes Colorectal Cancer Cell Progression by Regulating the PI3K/Akt Signaling Pathway.
    Song W; Mei JZ; Zhang M
    Oncol Res; 2018 Mar; 26(2):261-268. PubMed ID: 28835319
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.